Hirsch, Ian;
Goldstein, Daniel A;
Tannock, Ian F;
Butler, Marcus O;
Gilbert, Duncan C;
(2022)
Optimizing the dose and schedule of immune checkpoint inhibitors in cancer to allow global access.
Nature Medicine
, 28
pp. 2236-2237.
10.1038/s41591-022-02029-1.
Preview |
Text
Gilbert_12-2022-Gilbert_checkpoint_Corr_R1_Final.pdf - Accepted Version Download (152kB) | Preview |
| Type: | Article |
|---|---|
| Title: | Optimizing the dose and schedule of immune checkpoint inhibitors in cancer to allow global access |
| Location: | United States |
| Open access status: | An open access version is available from UCL Discovery |
| DOI: | 10.1038/s41591-022-02029-1 |
| Publisher version: | https://doi.org/10.1038/s41591-022-02029-1 |
| Language: | English |
| Additional information: | This version is the author accepted manuscript. For information on re-use, please refer to the publisher’s terms and conditions. |
| Keywords: | Cancer immunotherapy, Randomized controlled trials |
| UCL classification: | UCL UCL > Provost and Vice Provost Offices > School of Life and Medical Sciences UCL > Provost and Vice Provost Offices > School of Life and Medical Sciences > Faculty of Population Health Sciences > Inst of Clinical Trials and Methodology UCL > Provost and Vice Provost Offices > School of Life and Medical Sciences > Faculty of Population Health Sciences > Inst of Clinical Trials and Methodology > MRC Clinical Trials Unit at UCL |
| URI: | https://discovery.ucl.ac.uk/id/eprint/10158709 |
Downloads since deposit
48Downloads
Download activity - last month
Download activity - last 12 months
Downloads by country - last 12 months
Archive Staff Only
 |
View Item |
